William Fearon, MD

Back to Profile

Publication Details

  • Safety and performance of targeted renal therapy: the Be-RITe! Registry.

    Weisz G, Filby SJ, Cohen MG, Allie DE, Weinstock BS, Kyriazis D, Walker CM, Moses JW, Danna P, Fearon WF, Sachdev N, Wiechmann BN, Vora K, Findeiss L, Price MJ, Mehran R, Leon MB, Teirstein PS. J Endovasc Ther. 2009; 16 (1): 1-12

    To evaluate the safety and patterns of use of targeted renal therapy (TRT) with the Benephit system. TRT, the delivery of therapeutic agents directly to the kidneys by renal arterial infusion, has the advantage of providing a higher local effective dose with potentially greater renal effects, while limiting systemic adverse effects due to renal first-pass elimination.

    PubMedID: 19281283

Stanford Medicine Resources:

Footer Links: